Epigenetic testing opens new doors for multiple myeloma treatment

FHS
October 7, 2024
11:28 pm

Multiple myeloma is a type of blood cancer that appears mainly after the age of sixty. Its incidence, therefore, increases with the aging of the population.

Do probiotics supplements really make a difference during antibiotic treatment? Probably not, says research

Researchers evaluated previous work conducting controlled trials of patients undergoing antibiotic therapy.

July 24, 2023

CDC: Nirsevimab 90% Effective Against RSV Hospitalization in Infants

Immunizing infants in their first respiratory syncytial virus (RSV) season with nirsevimab (Beyfortus) proved highly protective against severe disease, a case-control study showed. From October

March 9, 2024

Fixing pulse oximeters requires federal might and possible legal action, researchers say

Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration

December 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.